Rafael S. Wurzel
Corporate Officer/Principal bei New Britain General Hospital
Profil
Rafael S.
Wurzel is the founder of Urovalve, Inc. which was founded in 1999.
He held the title of Director at the company.
Currently, he is the Chief of Urology at New Britain General Hospital.
Aktive Positionen von Rafael S. Wurzel
| Unternehmen | Position | Beginn |
|---|---|---|
New Britain General Hospital
 New Britain General Hospital Hospital/Nursing ManagementHealth Services New Britain General Hospital is an American company. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Rafael S. Wurzel
| Unternehmen | Position | Ende |
|---|---|---|
Urovalve, Inc.
 Urovalve, Inc. Medical DistributorsDistribution Services Urovalve, Inc. develops and manufactures urinary flow and control products. It has developed and patented technology to control fluid flow through small diameter flexible tubing. The core proprietary technology for the Surinate bladder management system is comprised of a simple magnetically controlled valve that can be activated remotely by a Surinate wearer who uses a hand held magnet to self-regulate flow. Currently available devices require continuous bladder drainage or insertion of a tube into the urethra several times each day. The Surinate bladder management system provides a solution to the problems of life style, urinary tract infections, and substantial healthcare worker expenses associated with existing catheters. The company was founded by Sergio Rothstein and Rafael S. Wurzel in 1999 and is headquartered in Newark, NJ. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Urovalve, Inc.
Urovalve, Inc. Medical DistributorsDistribution Services Urovalve, Inc. develops and manufactures urinary flow and control products. It has developed and patented technology to control fluid flow through small diameter flexible tubing. The core proprietary technology for the Surinate bladder management system is comprised of a simple magnetically controlled valve that can be activated remotely by a Surinate wearer who uses a hand held magnet to self-regulate flow. Currently available devices require continuous bladder drainage or insertion of a tube into the urethra several times each day. The Surinate bladder management system provides a solution to the problems of life style, urinary tract infections, and substantial healthcare worker expenses associated with existing catheters. The company was founded by Sergio Rothstein and Rafael S. Wurzel in 1999 and is headquartered in Newark, NJ. | Distribution Services |
New Britain General Hospital
New Britain General Hospital Hospital/Nursing ManagementHealth Services New Britain General Hospital is an American company. | Health Services |
